BDBM63272 MLS000700679::N'-{[5-(dimethylamino)-2-furyl]methylene}-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide::N-[[5-(dimethylamino)-2-furanyl]methylideneamino]-2,3-dihydro-1,4-benzodioxin-3-carboxamide::N-[[5-(dimethylamino)-2-furyl]methyleneamino]-2,3-dihydro-1,4-benzodioxin-3-carboxamide::N-[[5-(dimethylamino)furan-2-yl]methylideneamino]-2,3-dihydro-1,4-benzodioxine-3-carboxamide::SMR000225672::cid_15944944

SMILES COc1cc(Nc2nc(-c3ccc4c(c3)N=CC4)cn3ncnc23)ccc1N1CC2(COC2)C1

InChI Key InChIKey=UUEOYLHPWXEMAE-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 63272   

TargetTyrosine-protein kinase SYK(Human)
Nanjing Ruijie Pharma Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 63272BDBM63272(6-(3H-indol-6-yl)-N-(3-methoxy-4-(2-oxa-6-azaspiro...)
Affinity DataIC50: 50nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent